Trends in the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among ischemic stroke patients.
Saved in:
| Title: | Trends in the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among ischemic stroke patients. |
|---|---|
| Authors: | Ding Q; College of Health and Human Sciences, Purdue University, 502 N. University Street, West Lafayette, IN, USA. priscillading@purdue.edu., Sico JJ; Pain Research, Informatics, and Multi-morbidities, and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, USA.; Neurology Service, VA Connecticut Healthcare System, West Haven, CT, USA.; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Perkins AJ; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA., Myers LJ; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Daggy JK; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA., Sexson A; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA., Taylor SE; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA., Burrone L; Pain Research, Informatics, and Multi-morbidities, and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, USA., Waddell K; VA Center for Health Equity Research and Promotion (CHERP), Crescenz VA Medical Center, Philadelphia, PA, USA.; Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA, USA., Bravata DM; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.; Regenstrief Institute, Indianapolis, IN, USA.; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. |
| Source: | Cardiovascular diabetology. Endocrinology reports [Cardiovasc Diabetol Endocrinol Rep] 2026 Mar 10; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 9918994893106676 Publication Model: Electronic Cited Medium: Internet ISSN: 3059-4057 (Electronic) Linking ISSN: 30594057 NLM ISO Abbreviation: Cardiovasc Diabetol Endocrinol Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
